BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, June 8, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 8, 2017
View Archived Issues
FDA clears IND for phase II study of 177Lu-PSMA-617
Read More
Lupin identifies new PARP-1 inhibitors
Read More
Ono Pharmaceutical recaps milestones of third quarter of fiscal 2016
Read More
Clinical improvement in ADHD seen with fasoracetam in phase I trial, phase II/III study underway
Read More
AstraZeneca reviews milestones of fourth quarter 2016
Read More
Phase II trial results of RG-7667 for CMV infection prevention in kidney transplant recipients
Read More
HIF1-alpha identified as a target for relapsing triple-negative breast cancer
Read More
Longevity Biotech and UNMC awarded continuing grant for the development of LBT-3627
Read More
GW Pharmaceuticals reports topline results from phase II study of THC:CBD in glioblastoma
Read More
Nanjing Hairong, Nanjing Heron patent loxoprofen derivatives
Read More
FDA approves Parsabiv to treat secondary hyperparathyroidism in patients on hemodialysis
Read More
Amgen reflects on achievements of fourth quarter 2016
Read More
Sunshine Lake Pharma discloses 5-HT reuptake inhibitors/5-HT1A receptor agonists
Read More
Targeting zinc finger protein SNAI1 induces apoptosis in bladder cancer cells
Read More
Vyome Biosciences announces promising results for VB-1953
Read More
Marina Biotech signs licensing agreement for SMARTICLES platform
Read More
Flexion Therapeutics' Zilretta NDA accepted for review by FDA
Read More
FDA awards fast track designation to Angionetics' Generx
Read More
Investigator-sponsored phase I trial of Actinium Pharmaceuticals' Actimab-M begins
Read More
Buparlisib shows promise in patients with platinum-pretreated recurrent head and neck carcinoma
Read More
Acticor Biotech raises funds to advance lead candidate
Read More
GeNeuro, NINDS enter agreement regarding antibodies for ALS
Read More
Series B financing at Prexton Therapeutics to support phase II trials of foliglurax
Read More
Cancer Research Technology, Tusk Therapeutics and UCL collaborate on cancer immunotherapies
Read More
